Immunobiology of xenogeneic cornea grafts in mouse eyes: I. Fate of xenogeneic cornea tissue grafts implanted in anterior chamber of mouse eyes

Transplantation

Volumn 69, Issue 4, 2000, Pages 610-616

  Tanaka, Kazumi ^a   Yamada, Jun ^a   Joyce, Nancy ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANTERIOR EYE CHAMBER; ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA OPACITY; CORNEA TRANSPLANTATION; GRAFT FAILURE; GRAFT REJECTION; KERATITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

EID: 0034053947     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002270-00024     Document Type: Article

References (25)

1. The Collaborative Cornea Transplantation Studies Rsearch Group. The collaborative corneal transplantation studies (CCTS): Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392.
2. Coster DJ, Williams KA. Donor cornea procurement: some special problems in Asia. Asia-Pacific J Ophthalmol 1992; 4: 7.
3. Larkin DFK, Takano T, Standfield SD, Williams KA. Experimental orthotopic corneal xenotransplantation in the rat: Mechanisms of graft rejection. Transplantation 1995; 60: 491.
4. Auchincloss H. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
5. Platt JL. Xenotransplantation: recent progress and current perspectives. Curr Opin Immunol 1996; 8: 721.
6. Lawson JH, Platt JL. Molecular barriers to xenotransplantation. Transplantation 1996; 62: 303.
7. Auchincloss H, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433.
8. Goslings WRO, Prodeus AP, Streilein JW, Carroll MC, Jager MJ, Taylor AW. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest Ophthalmol Vis Sci 1998; 39: 989.
9. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature 1979; 282: 326.
10. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology 1982; 89: 700.
11. Rodrigues MM, Rowden G, Hackett J, Bakos I. Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci 1981; 21: 759.
12. Bergstresser PR, Fletcher CR, Streilein JW. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol 1980; 74: 77.
13. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS. Immunobiology of tissue transplantation: A return to the passenger leukocyte concept. Annu Rev Immunol 1983; 1: 143.
14. Niederkorn JY. Immune priviledge and immune regulation in the eye. Adv Immunol 1990; 48: 191.
15. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice - evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992; 54: 694.
16. Yamada J, Streilein JW. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber. Invest Ophthalmol Vis Sci 1997; 38: 2833.
17. Howarth AG, Hughes MR, Stevenson BR. Detection of the tight junction-associated protein ZO-1 in astrocytes and other non-epithelial cell types. Am J Physiol 1992; 262: 461.
18. Gardner TW, Lieth E, Khin SA, et al. Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 1997; 38; 2423.
19. Mitic LL, Anderson JM. Molecular architecture of tight junctions. Annu Rev Physiol 1998; 60: 121.
20. Ross JR, Howell DN, Sanfilippo FP. Characteristics of corneal xenograft rejection in a discordant species combination. Invest Ophthalmol Vis Sci 1993; 34: 2469.
21. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189.
22. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997; 99: 396.
23. Lass JH, Walter EI, Burris TE, et al. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci 1990; 31: 1136.
24. Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 1993; 34: 3579.
25. Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol 1994; 153: 1982.